Vinpo-15 Ingredients & Drug Interactions
by AOR Advanced Orthomolecular Research Premium
What is this page for?
First and foremost: checking Vinpo-15 against your medications. The heart of this page is the interaction checker and the full interaction report — how this product’s ingredients may interact with prescription and over-the-counter medicines you may be taking.
Around that, we add a pharmacist’s high-level view of the product as a whole — what’s inside, the evidence for its stated use, how transparent the label is, and what safety data exists — so you can see the full picture in one place. It’s educational information from our licensed clinical databases and the clinical staff at HelloPharmacist — not medical advice — and we don’t sell or endorse products. Our editorial policy
Vinpo-15 is a dietary supplement by AOR Advanced Orthomolecular Research Premium with 1 active ingredient. Its ingredients are commonly taken for memory and cognitive support, brain blood flow, stroke recovery.Based on those ingredients, 209 medications have a known interaction with it, the most serious rated moderate. The ingredients most likely to interact are Vinpocetine. Use the checker below to test your specific medication, or read the full HelloPharmacist Interaction Report.
Check Your Meds Against Vinpo-15 by AOR Advanced Orthomolecular Research Premium
Ask about any prescription or over-the-counter medication and we check it for interactions with Vinpo-15 by AOR Advanced Orthomolecular Research Premium — and tell you which ingredient is responsible.
AI summaries are generated from our interaction database for education only — always confirm with your pharmacist. How we use AI
Ask the Pharmacist
A licensed pharmacist will answer your question by email — free, usually within 24 hours.
Got it — thank you!
A licensed pharmacist will answer within 24 hours. Keep an eye on your email (worth checking spam, just in case).
HelloPharmacist Scorecard of Vinpo-15 by AOR Advanced Orthomolecular Research Premium
Our pharmacy team’s full take, with four database checks built into the cards below — a summary of what is known, not a grade of the product itself.
What’s inside
Full disclosure
Vinpo-15 contains one active ingredient: vinpocetine, a compound traditionally used to support circulation and cognition. The capsule itself and the microcrystalline cellulose and sodium stearyl fumarate inside are inactive ingredients (fillers and binders).
Does it work?
Moderate evidence
Vinpocetine is possibly effective for dementia based on the data we hold. For tinnitus, motion sickness, stroke, and chronic fatigue syndrome, the evidence isn't established well enough to rate.
That doesn't mean it doesn't work for those — just that the research available to us doesn't support a clear conclusion yet.
How safe is it?
Well-documented data
Vinpocetine is generally well tolerated in the short term, but long-term safety isn't well established. The most common side effects when taken by mouth are anxiety, dizziness, headache, flushing, stomach discomfort, sleep trouble, and hives.
Rare serious effects include very low white blood cell counts (agranulocytosis), irregular heartbeat, and seizures. The safety data advises against use in pregnancy.
There isn't enough safety information on file to know whether it's safe while breastfeeding — talk with your doctor or pharmacist before using it if you're nursing.
Meds to double-check
Moderate interaction found
Before taking Vinpo-15, double-check with your doctor or pharmacist if you take any anticoagulant or antiplatelet drugs (like aspirin, clopidogrel, or other blood thinners) — vinpocetine may increase bleeding risk. Also confirm if you're on warfarin or any drugs metabolized by the CYP2C9 liver pathway, since vinpocetine could affect how they work.
The bottom line
Scorecard at a glanceFully disclosed formula with some supporting evidence for its stated purpose. Moderate medication interactions have been identified, and safety information is well characterized.
Vinpo-15 may be worth considering if you're interested in possibly supporting cognition in dementia, but it's not the right fit if you take blood thinners or antiplatelet medications — the bleeding risk is real. Before you start this supplement, check with your own doctor or pharmacist about your current medications, especially anything that thins your blood or is broken down by your liver.
Educational only — not medical advice; always confirm with your pharmacist. Our editorial policy · How we use AI
Assessment coverage: 1 of 1 active ingredient matched to our full ingredient reviews (monographs). Based on the product label dated Mar 24, 2020.
This Scorecard evaluates available label information, ingredient evidence, and known medication-safety considerations. It does not independently verify product identity, purity, potency, contamination, or manufacturing quality. How these ratings are computed
General information
Key facts about Vinpo-15, straight from the product label.
| Brand | AOR Advanced Orthomolecular Research Premium |
|---|---|
| Barcode (UPC) | 624917080285 |
| Net contents | 90 Vegetarian Capsule(s) |
| Market status | On market |
| Date entered into DSLD | Mar 24, 2020 |
| DSLD ID | 214742 |
| Product type | Non-nutrient/non-botanical |
| Supplement form | Capsule |
| Dietary claims / uses | All Other, Structure/Function |
| Intended target group(s) | Vegan, Vegetarian, Adult (18 - 50 Years), Women (not pregnant or lactating), Gluten Free, Dairy Free |
Everything in this section is reproduced from the manufacturer’s own product label — it’s the label speaking, not HelloPharmacist. We show it so you can see exactly what the maker states; we don’t verify or endorse those statements.
Supplement Facts
The label details for Vinpo-15 by AOR Advanced Orthomolecular Research Premium, sourced from the NIH Dietary Supplement Label Database.
Supplement Facts
| Ingredient | Amount | % DV |
|---|---|---|
| Vinpocetine | 45 mg | -- |
Other ingredients: Capsule, Microcrystalline Cellulose, Sodium Stearyl Fumarate
Tap any ingredient to jump to its full detail below.
These statements are the manufacturer’s wording, reproduced from the product label — the label is saying it, not HelloPharmacist. We don’t verify or endorse them.
Formulation
GMP Manufacturing Quality assured Independent testing
Supports optimal brain function
Vegan
Non-GMO Gluten free
AOR guarantees that all ingredients have been declared on the label.
Made without wheat, gluten, corn, nuts, peanuts, sesame seeds, sulfites, mustard, soy, dairy, eggs, fish, shellfish or any animal byproduct.
Precautions
Do not use if safety seal is broken
Warning: Do not take if you are pregnant or lactating, have a medical condition (high or low blood pressure, cardiac arrhythmia, dementia, or have suffered a stroke), or if you’re taking any medication (blood thinners).
Keep out of reach of children.
Caution: Hypersensitivity is known to occur, and some people may experience anxiety, gastrointestinal discomfort, dizziness or headaches, in which case, discontinue use.
To report a serious adverse event or obtain product information, call 1-866-215-0450
Storage
Store tightly sealed in a cool, dry place
Formula
Discussion: Vinpo-15 is vinpocetine, a compound found in voacanga. Studies show that vinpocetine has similar benefits to Ginkgo biloba.
Suggested/Recommended/Usage/Directions
Directions: Take 1 capsules 1-3 times a day with food, or as directed by a qualified health care practitioner.
FDA Disclaimer Statement
These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.
FDA Statement of Identity
Dietary Supplement
General Statements
Product of Canada
Is this label outdated? Report a formula or label change and our pharmacy team will review it.
Vinpo-15 by AOR Advanced Orthomolecular Research Premium label
The label scan from the NIH Dietary Supplement Label Database. Tap to enlarge.
Label images are published by the NIH Dietary Supplement Label Database for the version of this product on file. Always read your actual product label.
View the full label (PDF)The Ingredients in Vinpo-15 by AOR Advanced Orthomolecular Research Premium
This is the 1 active ingredient this product is made of. Select it to open its full monograph.
Serving size1 Capsule(s) Dosage formCapsule Servings per container90 Amounts shown are per serving.
Vinpocetine
Interacts with209 drugs
Vinpocetine is a lab-made compound based on a chemical from the periwinkle plant, and it is marketed mainly for memory and brain health. The evidence...
Vinpocetine monograph & interactionsOther (inactive) ingredients: Capsule, Microcrystalline Cellulose, Sodium Stearyl Fumarate. These complete the product’s ingredient list but are not active constituents.
Vinpo-15 by AOR Advanced Orthomolecular Research Premium Drug Interactions
HelloPharmacist Interaction Report
Vinpo-15 from AOR Advanced Orthomolecular Research Premium contains vinpocetine, which interacts with multiple medication types.
The most serious documented interaction is Moderate severity with anticoagulant and antiplatelet drugs — vinpocetine can thin your blood further and raise your bleeding risk. It also carries Moderate risk with drugs broken down by the CYP2C9 liver pathway (theoretically raising their levels in your body, though this hasn't been seen in people yet).
Warfarin (a common blood thinner) gets its own Minor-severity interaction: modest increases in bleeding risk, though the actual changes measured in research were small.
Read the full breakdown — every affected drug type, severity by severity
Although these are the only interaction categories we hold data for, you should review your specific medications before taking this product. Altogether, these interactions span 208 individual medications.
Check your own medications below · Editorial policy · How we use AI
Want to check YOUR meds against Vinpo-15?
Ask about interactions with your drugs in plain English — “Can I take it with lisinopril?” — and we find you the answer in seconds, ingredient by ingredient.
Go to the checkerIngredients driving the most interactions
Individual Drug Interactions
The ingredients in Vinpo-15 interact with 209 drugs. Click any drug to see the details.
1 of the 1 ingredient in Vinpo-15 interact with drugs. Each result below shows which ingredient is responsible. Vinpocetine
AbciximabReoPro
How Abciximab interacts with Vinpo-15 — through 1 ingredient. Tap an ingredient for the detail:
VinpocetineAnticoagulant/antiplatelet Drugs Moderate
Interaction Summary
Vinpocetine might increase the risk of bleeding when taken with anticoagulant or antiplatelet drugs.
Read the full Vinpocetine + Abciximab interactionAbrocitinibCibinqo
How Abrocitinib interacts with Vinpo-15 — through 1 ingredient. Tap an ingredient for the detail:
VinpocetineCytochrome P450 2c9 (cyp2c9) Substrates, Anticoagulant/antiplatelet Drugs Moderate
Interaction Summary
Theoretically, vinpocetine might increase levels of drugs metabolized by CYP2C9.
Read the full Vinpocetine + Abrocitinib interactionAcenocoumarolSintrom
How Acenocoumarol interacts with Vinpo-15 — through 1 ingredient. Tap an ingredient for the detail:
VinpocetineAnticoagulant/antiplatelet Drugs Moderate
Interaction Summary
Vinpocetine might increase the risk of bleeding when taken with anticoagulant or antiplatelet drugs.
Read the full Vinpocetine + Acenocoumarol interactionAcetaminophen, AspirinGemnisyn
How Acetaminophen, Aspirin interacts with Vinpo-15 — through 1 ingredient. Tap an ingredient for the detail:
VinpocetineAnticoagulant/antiplatelet Drugs Moderate
Interaction Summary
Vinpocetine might increase the risk of bleeding when taken with anticoagulant or antiplatelet drugs.
Read the full Vinpocetine + Acetaminophen, Aspirin interactionAcetaminophen, Aspirin, CaffeineExcedrin, Excedrin Extra Strength, Excedrin Migraine
How Acetaminophen, Aspirin, Caffeine interacts with Vinpo-15 — through 1 ingredient. Tap an ingredient for the detail:
VinpocetineAnticoagulant/antiplatelet Drugs Moderate
Interaction Summary
Vinpocetine might increase the risk of bleeding when taken with anticoagulant or antiplatelet drugs.
Read the full Vinpocetine + Acetaminophen, Aspirin, Caffeine interactionAcetaminophen, IbuprofenCombogesic
How Acetaminophen, Ibuprofen interacts with Vinpo-15 — through 1 ingredient. Tap an ingredient for the detail:
VinpocetineCytochrome P450 2c9 (cyp2c9) Substrates, Anticoagulant/antiplatelet Drugs Moderate
Interaction Summary
Theoretically, vinpocetine might increase levels of drugs metabolized by CYP2C9.
Read the full Vinpocetine + Acetaminophen, Ibuprofen interactionAcetylsalicylic AcidEntrophen
How Acetylsalicylic Acid interacts with Vinpo-15 — through 1 ingredient. Tap an ingredient for the detail:
VinpocetineAnticoagulant/antiplatelet Drugs Moderate
Interaction Summary
Vinpocetine might increase the risk of bleeding when taken with anticoagulant or antiplatelet drugs.
Read the full Vinpocetine + Acetylsalicylic Acid interactionAerosphere Budesonide, Formoterol Fumarate, GlycopyrrolateBreztri
How Aerosphere Budesonide, Formoterol Fumarate, Glycopyrrolate interacts with Vinpo-15 — through 1 ingredient. Tap an ingredient for the detail:
VinpocetineCytochrome P450 2c9 (cyp2c9) Substrates Moderate
Interaction Summary
Theoretically, vinpocetine might increase levels of drugs metabolized by CYP2C9.
Read the full Vinpocetine + Aerosphere Budesonide, Formoterol Fumarate, Glycopyrrolate interactionAgomelatineValdoxan
How Agomelatine interacts with Vinpo-15 — through 1 ingredient. Tap an ingredient for the detail:
VinpocetineCytochrome P450 2c9 (cyp2c9) Substrates Moderate
Interaction Summary
Theoretically, vinpocetine might increase levels of drugs metabolized by CYP2C9.
Read the full Vinpocetine + Agomelatine interactionAlteplase, TpaActilyse, Activase
How Alteplase, Tpa interacts with Vinpo-15 — through 1 ingredient. Tap an ingredient for the detail:
VinpocetineAnticoagulant/antiplatelet Drugs Moderate
Interaction Summary
Vinpocetine might increase the risk of bleeding when taken with anticoagulant or antiplatelet drugs.
Read the full Vinpocetine + Alteplase, Tpa interactionAluminum Hydroxide, Aspirin, Codeine Phosphate, Magnesium HydroxideAscriptin Codeine #2
How Aluminum Hydroxide, Aspirin, Codeine Phosphate, Magnesium Hydroxide interacts with Vinpo-15 — through 1 ingredient. Tap an ingredient for the detail:
VinpocetineAnticoagulant/antiplatelet Drugs Moderate
Interaction Summary
Vinpocetine might increase the risk of bleeding when taken with anticoagulant or antiplatelet drugs.
Read the full Vinpocetine + Aluminum Hydroxide, Aspirin, Codeine Phosphate, Magnesium Hydroxide interactionAluminum Hydroxide, Aspirin, Magnesium HydroxideAscriptin
How Aluminum Hydroxide, Aspirin, Magnesium Hydroxide interacts with Vinpo-15 — through 1 ingredient. Tap an ingredient for the detail:
VinpocetineAnticoagulant/antiplatelet Drugs Moderate
Interaction Summary
Vinpocetine might increase the risk of bleeding when taken with anticoagulant or antiplatelet drugs.
Read the full Vinpocetine + Aluminum Hydroxide, Aspirin, Magnesium Hydroxide interactionAmitriptylineElavil
How Amitriptyline interacts with Vinpo-15 — through 1 ingredient. Tap an ingredient for the detail:
VinpocetineCytochrome P450 2c9 (cyp2c9) Substrates Moderate
Interaction Summary
Theoretically, vinpocetine might increase levels of drugs metabolized by CYP2C9.
Read the full Vinpocetine + Amitriptyline interactionAmitriptyline, ChlordiazepoxideLimbitrol DS
How Amitriptyline, Chlordiazepoxide interacts with Vinpo-15 — through 1 ingredient. Tap an ingredient for the detail:
VinpocetineCytochrome P450 2c9 (cyp2c9) Substrates Moderate
Interaction Summary
Theoretically, vinpocetine might increase levels of drugs metabolized by CYP2C9.
Read the full Vinpocetine + Amitriptyline, Chlordiazepoxide interactionAmitriptyline, PerphenazineEtrafon, Etrafon-A, Etrafon-Forte, Triavil
How Amitriptyline, Perphenazine interacts with Vinpo-15 — through 1 ingredient. Tap an ingredient for the detail:
VinpocetineCytochrome P450 2c9 (cyp2c9) Substrates Moderate
Interaction Summary
Theoretically, vinpocetine might increase levels of drugs metabolized by CYP2C9.
Read the full Vinpocetine + Amitriptyline, Perphenazine interactionAmlodipine, CelecoxibConsensi
How Amlodipine, Celecoxib interacts with Vinpo-15 — through 1 ingredient. Tap an ingredient for the detail:
VinpocetineCytochrome P450 2c9 (cyp2c9) Substrates Moderate
Interaction Summary
Theoretically, vinpocetine might increase levels of drugs metabolized by CYP2C9.
Read the full Vinpocetine + Amlodipine, Celecoxib interactionAmoxicillin, Omeprazole Magnesium, RifabutinTalicia
How Amoxicillin, Omeprazole Magnesium, Rifabutin interacts with Vinpo-15 — through 1 ingredient. Tap an ingredient for the detail:
VinpocetineCytochrome P450 2c9 (cyp2c9) Substrates Moderate
Interaction Summary
Theoretically, vinpocetine might increase levels of drugs metabolized by CYP2C9.
Read the full Vinpocetine + Amoxicillin, Omeprazole Magnesium, Rifabutin interactionAnacaulase-bcdbNexoBrid
How Anacaulase-bcdb interacts with Vinpo-15 — through 1 ingredient. Tap an ingredient for the detail:
VinpocetineAnticoagulant/antiplatelet Drugs Moderate
Interaction Summary
Vinpocetine might increase the risk of bleeding when taken with anticoagulant or antiplatelet drugs.
Read the full Vinpocetine + Anacaulase-bcdb interactionAnagrelideAgrylin
How Anagrelide interacts with Vinpo-15 — through 1 ingredient. Tap an ingredient for the detail:
VinpocetineAnticoagulant/antiplatelet Drugs Moderate
Interaction Summary
Vinpocetine might increase the risk of bleeding when taken with anticoagulant or antiplatelet drugs.
Read the full Vinpocetine + Anagrelide interactionAnisindioneMiradon
How Anisindione interacts with Vinpo-15 — through 1 ingredient. Tap an ingredient for the detail:
VinpocetineAnticoagulant/antiplatelet Drugs Moderate
Interaction Summary
Vinpocetine might increase the risk of bleeding when taken with anticoagulant or antiplatelet drugs.
Read the full Vinpocetine + Anisindione interactionAntithrombin IiiThrombate III
How Antithrombin Iii interacts with Vinpo-15 — through 1 ingredient. Tap an ingredient for the detail:
VinpocetineAnticoagulant/antiplatelet Drugs Moderate
Interaction Summary
Vinpocetine might increase the risk of bleeding when taken with anticoagulant or antiplatelet drugs.
Read the full Vinpocetine + Antithrombin Iii interactionApixabanEliquis
How Apixaban interacts with Vinpo-15 — through 1 ingredient. Tap an ingredient for the detail:
VinpocetineAnticoagulant/antiplatelet Drugs Moderate
Interaction Summary
Vinpocetine might increase the risk of bleeding when taken with anticoagulant or antiplatelet drugs.
Read the full Vinpocetine + Apixaban interactionArgatrobanArgatroban
How Argatroban interacts with Vinpo-15 — through 1 ingredient. Tap an ingredient for the detail:
VinpocetineAnticoagulant/antiplatelet Drugs Moderate
Interaction Summary
Vinpocetine might increase the risk of bleeding when taken with anticoagulant or antiplatelet drugs.
Read the full Vinpocetine + Argatroban interactionAspirinAngettes 75, ASA, Asaphen, Aspirin, Caprin, Cartia +8 more
How Aspirin interacts with Vinpo-15 — through 1 ingredient. Tap an ingredient for the detail:
VinpocetineAnticoagulant/antiplatelet Drugs Moderate
Interaction Summary
Vinpocetine might increase the risk of bleeding when taken with anticoagulant or antiplatelet drugs.
Read the full Vinpocetine + Aspirin interactionAspirin, Aluminum Hydroxide, Codeine Phosphate, Magnesium HydroxideAscriptin Codeine #3
How Aspirin, Aluminum Hydroxide, Codeine Phosphate, Magnesium Hydroxide interacts with Vinpo-15 — through 1 ingredient. Tap an ingredient for the detail:
VinpocetineAnticoagulant/antiplatelet Drugs Moderate
Interaction Summary
Vinpocetine might increase the risk of bleeding when taken with anticoagulant or antiplatelet drugs.
Read the full Vinpocetine + Aspirin, Aluminum Hydroxide, Codeine Phosphate, Magnesium Hydroxide interactionAspirin, ButalbitalAxotal
How Aspirin, Butalbital interacts with Vinpo-15 — through 1 ingredient. Tap an ingredient for the detail:
VinpocetineAnticoagulant/antiplatelet Drugs Moderate
Interaction Summary
Vinpocetine might increase the risk of bleeding when taken with anticoagulant or antiplatelet drugs.
Read the full Vinpocetine + Aspirin, Butalbital interactionAspirin, Butalbital, CaffeineFiorinal
How Aspirin, Butalbital, Caffeine interacts with Vinpo-15 — through 1 ingredient. Tap an ingredient for the detail:
VinpocetineAnticoagulant/antiplatelet Drugs Moderate
Interaction Summary
Vinpocetine might increase the risk of bleeding when taken with anticoagulant or antiplatelet drugs.
Read the full Vinpocetine + Aspirin, Butalbital, Caffeine interactionAspirin, Butalbital, Caffeine, Codeine PhosphateFiorinal w/ Codeine
How Aspirin, Butalbital, Caffeine, Codeine Phosphate interacts with Vinpo-15 — through 1 ingredient. Tap an ingredient for the detail:
VinpocetineAnticoagulant/antiplatelet Drugs Moderate
Interaction Summary
Vinpocetine might increase the risk of bleeding when taken with anticoagulant or antiplatelet drugs.
Read the full Vinpocetine + Aspirin, Butalbital, Caffeine, Codeine Phosphate interactionAspirin, Butalbital, Caffeine, PhenacetinMarnal
How Aspirin, Butalbital, Caffeine, Phenacetin interacts with Vinpo-15 — through 1 ingredient. Tap an ingredient for the detail:
VinpocetineAnticoagulant/antiplatelet Drugs Moderate
Interaction Summary
Vinpocetine might increase the risk of bleeding when taken with anticoagulant or antiplatelet drugs.
Read the full Vinpocetine + Aspirin, Butalbital, Caffeine, Phenacetin interactionAspirin, CaffeineAnacin
How Aspirin, Caffeine interacts with Vinpo-15 — through 1 ingredient. Tap an ingredient for the detail:
VinpocetineAnticoagulant/antiplatelet Drugs Moderate
Interaction Summary
Vinpocetine might increase the risk of bleeding when taken with anticoagulant or antiplatelet drugs.
Read the full Vinpocetine + Aspirin, Caffeine interactionEach ingredient & the kinds of drugs it affects
For each ingredient in Vinpo-15 with known interactions, here are the types of medications it can affect. Open any type for the detail — or search your exact drug in the checker above.
Vinpocetine
Anticoagulant/Antiplatelet Drugs
Vinpocetine might increase the risk of bleeding when taken with anticoagulant or antiplatelet drugs.
Clinical research shows that vinpocetine decreases red blood cell aggregation, as well as plasma and whole blood viscosity. This effect has been seen with intravenous vinpocetine 1 mg/kg and oral vinpocetine 30 mg daily. Vinpocetine also seems to have antiplatelet effects.
Cytochrome P450 2C9 (Cyp2C9) Substrates
Theoretically, vinpocetine might increase levels of drugs metabolized by CYP2C9.
In vitro research shows that vinpocetine weakly inhibits CYP2C9. However, this effect has not been reported in humans.
Warfarin (Coumadin)
Vinpocetine might modestly increase the risk of bleeding when taken with warfarin.
Clinical research shows that the combination of warfarin and vinpocetine leads to slight increases in prothrombin time and the area under the concentration curve for warfarin. However, these increases were small, and researchers suggest that this interaction is not likely to be clinically significant in most patients.
Brand information
Manufacturer and brand details for Vinpo-15, from the product label.
AOR Advanced Orthomolecular Research Premium
See all AOR Advanced Orthomolecular Research Premium products- Name
- AOR Inc.
- Street Address
- 30 Industrial West
- City
- Clifton
- State
- NJ
- ZipCode
- 07012
- Phone Number
- 1-866-215-0450
Vinpo-15 by AOR Advanced Orthomolecular Research Premium: Common Questions
Does Vinpo-15 by AOR Advanced Orthomolecular Research Premium interact with any medications?
How can one product interact with so many drugs?
Where does this information come from?
Can I take Vinpo-15 if I'm pregnant or breastfeeding?
What are the most common side effects?
Does vinpocetine really work for dementia?
Why does the label say this might increase bleeding?
Is this safe to take long-term?
Written and reviewed by the HelloPharmacist editorial staff. Our editorial policy
Not sure if Vinpo-15 is safe with your meds?
Our pharmacists answer your medication & supplement questions — free.
Label information is sourced from the NIH Dietary Supplement Label Database and reflects the product version on file; always read your actual product label. This page is for education only and is not a substitute for professional medical advice. Confirm with your pharmacist or doctor before combining supplements and medications.
The Full Monographs Behind Vinpo-15’s Ingredients
Every ingredient we hold a full HelloPharmacist monograph for — uses, evidence, safety, and the complete interaction list.
Sources & How We Checked
Vinpo-15's label data comes from the NIH Dietary Supplement Label Database; the ingredient interaction data is from the Natural Medicines database, reviewed by our pharmacists.
- NIH Dietary Supplement Label Database (DSLD) — The official product label on file for this supplement.
- Natural Medicines (Therapeutic Research Center) — Evidence-graded clinical reference behind the ingredient interaction data.
Content is written and reviewed by licensed HelloPharmacist pharmacists. See our data sources and editorial standards for how this information is built and checked.
The 27 references behind this product’s interaction data
Every citation that drives the interaction findings for this product’s ingredients, from the evidence-graded Natural Medicines (TRC Healthcare) database. Open an ingredient to browse its citations — links open the study on PubMed or the publisher’s site.
Vinpocetine 27 references
- Hindmarch I, Fuchs HH, Erzigkeit H. Efficacy and tolerance of vinpocetine in ambulant patients suffering from mild to moderate organic psychosyndromes. Int Clin Psychopharmacol 1991;6:31-43. PubMed
- Balestreri R, Fontana L, Astengo F. A double-blind placebo controlled evaluation of the safety and efficacy of vinpocetine in the treatment of patients with chronic vascular senile cerebral dysfunction. J Am Geriatr Soc 1987;35:425-30. PubMed
- Akopov SE, Gabrielian ES. Effects of aspirin, dipyridamole, nifedipine and cavinton which act on platelet aggregation induced by different aggregating agents alone and in combination. Eur J Clin Pharmacol 1992;42:257-9. PubMed
- Kidd PM. A review of nutrients and botanicals in the integrative management of cognitive dysfunction. Altern Med Rev 1999;4:144-61..
- Wollschlaeger B. Efficacy of vinpocetine in the management of cognitive impairment and memory loss. JANA 2001;4:25-30.
- Hitzenberger G, Sommer W, Grandt R. Influence of vinpocetine on warfarin-induced inhibition of coagulation. Int J Clin Pharmacol Ther Toxicol 1990;28:323-8..
- Dekoninck, W. J., Jocquet, P., Jacquy, J., and Henriet, M. Comparative study of the clinical effects of vincamine + glycerol versus glycerol + placebo in the acute phase of stroke. Arzneimittelforschung. 1978;28(9):1654-1657.
- Fischhof, P. K., Moslinger-Gehmayr, R., Herrmann, W. M., Friedmann, A., and Russmann, D. L. Therapeutic efficacy of vincamine in dementia. Neuropsychobiology 1996;34(1):29-35. PubMed
- Feher, G., Koltai, K., Kesmarky, G., Horvath, B., Toth, K., Komoly, S., and Szapary, L. Effect of parenteral or oral vinpocetine on the hemorheological parameters of patients with chronic cerebrovascular diseases. Phytomedicine. 2009;16(2-3):111-117. PubMed
- Kuzuya, F. Effects of vinpocetine on platelet aggregability and erythrocyte deformability. Ther Hung. 1985;33(1):22-34.
- Kovacs, L. Cavinton in the treatment of acute stroke. Ther Hung. 1985;33(1):50-57.
- Osawa, M. and Maruyama, S. Effects of TCV-3B (vinpocetine) on blood viscosity in ischemic cerebrovascular diseases. Ther.Hung. 1985;33(1):7-12.
- Ebi, O. Open-labeled phase III clinical trials with vinpocetine in Japan. Ther.Hung. 1985;33(1):41-49.
- Richichi, I., Valsecchi, O., Falcone, C., Sofi, A., and Zanini, L. [A case of "torsade de pointe" during vincamine therapy]. Minerva Cardioangiol. 1978;26(3):197-200.
- Dany, F., Merle, L., Goudoud, J. C., Liozon, F., Blanc, P., Bouvot, J. C., Nicot, G., and Dangoumau, J. [Cardiac toxicity of vincamine: a seven cases report of ventricular arrhythmias by parenteral administration of vincamine (author's transl)]. Therapie
- Fenzl, E., Apecechea, M., Schaltenbr, R., and Fridel, R. Long term study concerning tolerance and efficacy of vinpocetine in elderly patients suffering from a mild to moderate organic psychosyndrome. Senile dementia: early detection 1986;580-585.
- Peruzza, M. and DeJacobis, M. A double-blind placebo controlled evaluation of the efficacy and safety of vinpocetine in the treatment of patients with chronic vascular or degenerative senile cerebral dysfunction. ADV THER 1986;3(4):201-209.
- Manconi, E., Binaghi, F., and Pitzus, F. A double-blind clinical trial of vinpocetine in the treatment of cerebral insufficiency of vascular and degenerative origin. CURR THER RES, CLIN EXP 1986;40(4):702-709.
- Blaha, L., Erzigkeit, H. L., Adamczyk, L. A., Freytag, L. S., and Schaltenbrand, R. Clinical evidence of the effectiveness of vinpocetine in the treatment of organic psychosyndrome. Human Psychopharmacology: Clinical & Experimental 1989;4(2):103-111. DOI
- Shimizu, Y., Saitoh, K., Nakayama, M., Suto, K., Daikohara, R., and Nemoto, T. Agranulocytosis induced by vinpocetine. Medicine On-line 2011;
- Kong L, Song C, Ye L, et al. The Effect of Vinpocetine on Human Cytochrome P450 Isoenzymes by Using a Cocktail Method. Evid Based Complement Alternat Med. 2016;2016:5017135. PubMed
- Vinpocetine in Dietary Supplements. FDA Food/Dietary Supplements/Products & Ingredients. Available at: http://www.fda.gov/Food/DietarySupplements/ProductsIngredients/ucm518478.htm. Accessed 6 September 2016.
- Statement on warning for women of childbearing age about possible safety risks of dietary supplements containing vinpocetine. FDA Food/Dietary Supplements/Products & Ingredients. Available at: https://www.fda.gov/news-events/press-announcements/statement-
- Zhang W, Huang Y, Li Y, et al. Efficacy and safety of vinpocetine as part of treatment for acute cerebral infarction: A randomized, open-label, controlled, multicenter CAVIN (Chinese Assessment for Vinpocetine in Neurology) trial. Clin Drug Investig 2016; PubMed
- National Toxicology Program. NTP technical report on the prenatal development toxicity studies of vinpocetine (CAS No. 42971-09-5) in Sprague Dawley Rats and New Zealand White Rabbits (Gavage Studies). Research Triangle Park, NC: National Toxicology Progr
- Gutiérrez-Farfán I, Reyes-Legorreta C, Solís-Olguín M, Alatorre-Miguel E, Verduzco-Mendoza A, Durand-Rivera A. Evaluation of vinpocetine as a therapy in patients with sensorineural hearing loss: a phase II, open-label, single-center study. J Pharmacol Sci PubMed
- Hu X, Guo K, Li J, et al. Postoperative ecchymoma of eyelid after botulinum toxin injection for hemifacial spasm: a case report. Front Neurol 2023;14:1171303. PubMed
Parts of this content are provided by the Therapeutic Research Center, LLC.
DISCLAIMER: Currently this does not check for drug-drug interactions. This is not an all-inclusive comprehensive list of potential interactions and is for informational purposes only. Not all interactions are known or well-reported in the scientific literature, and new interactions are continually being reported. Input is needed from a qualified healthcare provider including a pharmacist before starting any therapy. Application of clinical judgment is necessary.
© 2021 Therapeutic Research Center, LLC